Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution

SARS-CoV-2 vaccines are effective in preventing COVID-19. Patients with cancer are at high risk for severe COVID-19 and are appropriately prioritized for vaccination. Several studies in this issue of Cancer Cell add to our knowledge of the heterogeneity of immune responses to vaccination among patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffiths, Elizabeth A., Segal, Brahm H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Preview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253695/
https://www.ncbi.nlm.nih.gov/pubmed/34242573
http://dx.doi.org/10.1016/j.ccell.2021.07.001
_version_ 1783717568789348352
author Griffiths, Elizabeth A.
Segal, Brahm H.
author_facet Griffiths, Elizabeth A.
Segal, Brahm H.
author_sort Griffiths, Elizabeth A.
collection PubMed
description SARS-CoV-2 vaccines are effective in preventing COVID-19. Patients with cancer are at high risk for severe COVID-19 and are appropriately prioritized for vaccination. Several studies in this issue of Cancer Cell add to our knowledge of the heterogeneity of immune responses to vaccination among patients with cancer and identify important areas for future research.
format Online
Article
Text
id pubmed-8253695
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-82536952021-07-06 Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution Griffiths, Elizabeth A. Segal, Brahm H. Cancer Cell Preview SARS-CoV-2 vaccines are effective in preventing COVID-19. Patients with cancer are at high risk for severe COVID-19 and are appropriately prioritized for vaccination. Several studies in this issue of Cancer Cell add to our knowledge of the heterogeneity of immune responses to vaccination among patients with cancer and identify important areas for future research. Elsevier Inc. 2021-08-09 2021-07-03 /pmc/articles/PMC8253695/ /pubmed/34242573 http://dx.doi.org/10.1016/j.ccell.2021.07.001 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Preview
Griffiths, Elizabeth A.
Segal, Brahm H.
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
title Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
title_full Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
title_fullStr Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
title_full_unstemmed Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
title_short Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
title_sort immune responses to covid-19 vaccines in patients with cancer: promising results and a note of caution
topic Preview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253695/
https://www.ncbi.nlm.nih.gov/pubmed/34242573
http://dx.doi.org/10.1016/j.ccell.2021.07.001
work_keys_str_mv AT griffithselizabetha immuneresponsestocovid19vaccinesinpatientswithcancerpromisingresultsandanoteofcaution
AT segalbrahmh immuneresponsestocovid19vaccinesinpatientswithcancerpromisingresultsandanoteofcaution

Ejemplares similares